Trade Journal Entry MNQ1! – Micro E-mini Nasdaq-100 Futures
Trader: Lord MEDZ
Date: Thursday, July 10, 2025
Instrument: MNQ1! – Micro E-mini Nasdaq-100 Futures
Timeframe: 5-Minute Chart
Strategy: Master OD + IDR + DR Setup
Entry Model: Goldbach PO3 81 | M1 + FVG Confluence
🧠 Narrative & Trade Idea
This setup was based on the Master OD, Initial Dealing Range (IDR), and Dealing Range (DR) model, incorporating a Goldbach PO3 81 entry on the 1-minute chart with a confirmation retest.
London Dealing Range (LON DR) was established, followed by a Break of Structure (BoS) confirming bullish intent.
Price extended to 0.5 Standard Deviation, where profit-taking and a pullback were expected.
The pullback offered a retest of the DR high and tapped into a 1-minute Fair Value Gap (FVG) – key for PO3 81 entries.
Price also interacted with an Order Block (OB) confluence around 23,011.
Trade entry was executed cleanly with tight risk and high R:R logic.
📍 Execution Details
Entry: 23,019.00
Stop Loss: 23,011.00
Target: 23,077.00
Risk: 8.00 pts
Reward: 58.00 pts
Position Size: 12 contracts
Total Risk: $148.50
Total Reward Potential: $1,623.75
Risk/Reward Ratio: 1:8.22 ✅
🔍 Technical Confluences
✅ Clean Break of Structure from LON DR highs
✅ Retest of DR zone aligned with 1-min Fair Value Gap
✅ Price tapped into Order Block + PO3 81 criteria met
✅ Entry model: Precision M1 PO3 81 + 1m/5m alignment
✅ Target aligned with premium OB zone + 1.0 ext level
📈 Trade Outcome & Lessons
The execution respected both structure and order flow principles.
PO3 81 delivered textbook performance off the retest.
Strong emotional discipline shown by holding for full R:R.
Setup validated the predictive strength of the Master OD + IDR system with Goldbach’s entry logic.
Trade active
Trade closed: target reached
Lord MEDZ
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Lord MEDZ
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.